XK and influenza: Although neuraminidase (NA) inhibitors are globally approved for influenza treatment, NA inhibitor-resistant viruses have already been isolated among seasonal H1N13,4, pandemic (H1N1) 20095–7, and even highly pathogenic avian H5N18,9 viruses.